nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—Tonsillitis—Metformin—metabolic syndrome X	0.0409	0.154	CcSEcCtD
Pimecrolimus—MTOR—blood vessel—metabolic syndrome X	0.0222	0.241	CbGeAlD
Pimecrolimus—Sinus congestion—Metformin—metabolic syndrome X	0.0207	0.0784	CcSEcCtD
Pimecrolimus—Loose stools—Metformin—metabolic syndrome X	0.0186	0.0705	CcSEcCtD
Pimecrolimus—Toothache—Metformin—metabolic syndrome X	0.017	0.0641	CcSEcCtD
Pimecrolimus—Rhinorrhoea—Metformin—metabolic syndrome X	0.0127	0.0482	CcSEcCtD
Pimecrolimus—MTOR—cardiovascular system—metabolic syndrome X	0.00988	0.107	CbGeAlD
Pimecrolimus—MTOR—kidney—metabolic syndrome X	0.00967	0.105	CbGeAlD
Pimecrolimus—FKBP1A—cardiovascular system—metabolic syndrome X	0.00889	0.0965	CbGeAlD
Pimecrolimus—Ear pain—Metformin—metabolic syndrome X	0.00878	0.0332	CcSEcCtD
Pimecrolimus—MTOR—adipose tissue—metabolic syndrome X	0.00871	0.0946	CbGeAlD
Pimecrolimus—FKBP1A—kidney—metabolic syndrome X	0.0087	0.0944	CbGeAlD
Pimecrolimus—Nasal congestion—Metformin—metabolic syndrome X	0.00822	0.0311	CcSEcCtD
Pimecrolimus—FKBP1A—adipose tissue—metabolic syndrome X	0.00784	0.0851	CbGeAlD
Pimecrolimus—Abdominal pain upper—Metformin—metabolic syndrome X	0.00684	0.0259	CcSEcCtD
Pimecrolimus—Breast disorder—Metformin—metabolic syndrome X	0.00677	0.0256	CcSEcCtD
Pimecrolimus—Nasopharyngitis—Metformin—metabolic syndrome X	0.0067	0.0253	CcSEcCtD
Pimecrolimus—Influenza—Metformin—metabolic syndrome X	0.00647	0.0245	CcSEcCtD
Pimecrolimus—MTOR—liver—metabolic syndrome X	0.00611	0.0664	CbGeAlD
Pimecrolimus—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00602	0.0227	CcSEcCtD
Pimecrolimus—Infestation—Metformin—metabolic syndrome X	0.00577	0.0218	CcSEcCtD
Pimecrolimus—Infestation NOS—Metformin—metabolic syndrome X	0.00577	0.0218	CcSEcCtD
Pimecrolimus—FKBP1A—liver—metabolic syndrome X	0.0055	0.0597	CbGeAlD
Pimecrolimus—Rhinitis—Metformin—metabolic syndrome X	0.0052	0.0196	CcSEcCtD
Pimecrolimus—Eye disorder—Metformin—metabolic syndrome X	0.00484	0.0183	CcSEcCtD
Pimecrolimus—Flushing—Metformin—metabolic syndrome X	0.00481	0.0182	CcSEcCtD
Pimecrolimus—Immune system disorder—Metformin—metabolic syndrome X	0.00468	0.0177	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Metformin—metabolic syndrome X	0.00467	0.0177	CcSEcCtD
Pimecrolimus—Erythema—Metformin—metabolic syndrome X	0.00451	0.0171	CcSEcCtD
Pimecrolimus—Malnutrition—Metformin—metabolic syndrome X	0.00451	0.0171	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00381	0.0144	CcSEcCtD
Pimecrolimus—Oedema—Metformin—metabolic syndrome X	0.00368	0.0139	CcSEcCtD
Pimecrolimus—Infection—Metformin—metabolic syndrome X	0.00366	0.0138	CcSEcCtD
Pimecrolimus—Nervous system disorder—Metformin—metabolic syndrome X	0.00361	0.0136	CcSEcCtD
Pimecrolimus—Skin disorder—Metformin—metabolic syndrome X	0.00358	0.0135	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00335	0.0127	CcSEcCtD
Pimecrolimus—Paraesthesia—Metformin—metabolic syndrome X	0.00331	0.0125	CcSEcCtD
Pimecrolimus—Dyspnoea—Metformin—metabolic syndrome X	0.00328	0.0124	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00318	0.012	CcSEcCtD
Pimecrolimus—Constipation—Metformin—metabolic syndrome X	0.00315	0.0119	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00301	0.0114	CcSEcCtD
Pimecrolimus—Urticaria—Metformin—metabolic syndrome X	0.00292	0.0111	CcSEcCtD
Pimecrolimus—Abdominal pain—Metformin—metabolic syndrome X	0.00291	0.011	CcSEcCtD
Pimecrolimus—CYP3A4—kidney—metabolic syndrome X	0.00284	0.0309	CbGeAlD
Pimecrolimus—Pruritus—Metformin—metabolic syndrome X	0.0026	0.00985	CcSEcCtD
Pimecrolimus—Diarrhoea—Metformin—metabolic syndrome X	0.00252	0.00952	CcSEcCtD
Pimecrolimus—Vomiting—Metformin—metabolic syndrome X	0.00234	0.00885	CcSEcCtD
Pimecrolimus—Rash—Metformin—metabolic syndrome X	0.00232	0.00878	CcSEcCtD
Pimecrolimus—Dermatitis—Metformin—metabolic syndrome X	0.00232	0.00877	CcSEcCtD
Pimecrolimus—Headache—Metformin—metabolic syndrome X	0.00231	0.00872	CcSEcCtD
Pimecrolimus—Nausea—Metformin—metabolic syndrome X	0.00219	0.00827	CcSEcCtD
Pimecrolimus—CYP3A4—liver—metabolic syndrome X	0.0018	0.0195	CbGeAlD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IRS1—metabolic syndrome X	0.000779	0.00121	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—IRS1—metabolic syndrome X	0.000779	0.00121	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—IRS1—metabolic syndrome X	0.000779	0.00121	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—IRS1—metabolic syndrome X	0.000772	0.0012	CbGpPWpGaD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—AKT1—metabolic syndrome X	0.000766	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—AKT1—metabolic syndrome X	0.000766	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—IRS1—metabolic syndrome X	0.000765	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—IRS1—metabolic syndrome X	0.000762	0.00118	CbGpPWpGaD
Pimecrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.000755	0.00117	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—TRIB3—metabolic syndrome X	0.000744	0.00116	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—metabolic syndrome X	0.000733	0.00114	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.000724	0.00112	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—IRS1—metabolic syndrome X	0.000721	0.00112	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—TRIB3—metabolic syndrome X	0.000715	0.00111	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—RBP4—metabolic syndrome X	0.000712	0.00111	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TRIB3—metabolic syndrome X	0.000712	0.00111	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—NOS3—metabolic syndrome X	0.000702	0.00109	CbGpPWpGaD
Pimecrolimus—MTOR—IL4-mediated signaling events—AKT1—metabolic syndrome X	0.000696	0.00108	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IRS1—metabolic syndrome X	0.00069	0.00107	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.000676	0.00105	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—AKT1—metabolic syndrome X	0.00067	0.00104	CbGpPWpGaD
Pimecrolimus—MTOR—mTOR signaling pathway—AKT1—metabolic syndrome X	0.000662	0.00103	CbGpPWpGaD
Pimecrolimus—MTOR—TSH signaling pathway—AKT1—metabolic syndrome X	0.000662	0.00103	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—metabolic syndrome X	0.000657	0.00102	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—G6PC2—metabolic syndrome X	0.000655	0.00102	CbGpPWpGaD
Pimecrolimus—MTOR—Regulation of Telomerase—AKT1—metabolic syndrome X	0.000646	0.001	CbGpPWpGaD
Pimecrolimus—MTOR—Costimulation by the CD28 family—AKT1—metabolic syndrome X	0.000646	0.001	CbGpPWpGaD
Pimecrolimus—MTOR—AMPK Signaling—AKT1—metabolic syndrome X	0.000639	0.000993	CbGpPWpGaD
Pimecrolimus—MTOR—SREBP signalling—AKT1—metabolic syndrome X	0.000639	0.000993	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NAMPT—metabolic syndrome X	0.000638	0.000992	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—GCK—metabolic syndrome X	0.000634	0.000986	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—APOC3—metabolic syndrome X	0.00063	0.00098	CbGpPWpGaD
Pimecrolimus—MTOR—Leptin signaling pathway—AKT1—metabolic syndrome X	0.000598	0.000929	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-mediated signalling—IL6—metabolic syndrome X	0.000586	0.000911	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—HMGA1—metabolic syndrome X	0.00058	0.000902	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HDAC3—metabolic syndrome X	0.000572	0.000889	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—LBP—metabolic syndrome X	0.000572	0.000889	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events—IL6—metabolic syndrome X	0.00057	0.000886	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—metabolic syndrome X	0.000568	0.000882	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events triggered by IGF1R—IL6—metabolic syndrome X	0.000565	0.000878	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—GOT2—metabolic syndrome X	0.000553	0.00086	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CYBA—metabolic syndrome X	0.000553	0.00086	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CYBA—metabolic syndrome X	0.000551	0.000856	CbGpPWpGaD
Pimecrolimus—MTOR—IGF1R signaling cascade—IL6—metabolic syndrome X	0.00055	0.000855	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin receptor signalling cascade—IL6—metabolic syndrome X	0.00055	0.000855	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—AKT1—metabolic syndrome X	0.000546	0.000849	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR4-mediated signaling events—AKT1—metabolic syndrome X	0.000546	0.000849	CbGpPWpGaD
Pimecrolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—AKT1—metabolic syndrome X	0.000536	0.000833	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—IRS1—metabolic syndrome X	0.000531	0.000825	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000511	0.000795	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.000503	0.000782	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TRIB3—metabolic syndrome X	0.000498	0.000775	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RBP4—metabolic syndrome X	0.000498	0.000775	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IL6—metabolic syndrome X	0.000495	0.000769	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—SLC2A4—metabolic syndrome X	0.000493	0.000767	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—metabolic syndrome X	0.000488	0.000758	CbGpPWpGaD
Pimecrolimus—MTOR—PI-3K cascade—AKT1—metabolic syndrome X	0.000483	0.00075	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—GOT1—metabolic syndrome X	0.000478	0.000742	CbGpPWpGaD
Pimecrolimus—MTOR—PI3K/AKT activation—AKT1—metabolic syndrome X	0.000471	0.000732	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PLA2G6—metabolic syndrome X	0.000471	0.000732	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—G6PD—metabolic syndrome X	0.000471	0.000732	CbGpPWpGaD
Pimecrolimus—MTOR—GAB1 signalosome—AKT1—metabolic syndrome X	0.000467	0.000726	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—IL6—metabolic syndrome X	0.00046	0.000715	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—HDAC3—metabolic syndrome X	0.000459	0.000714	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by Insulin receptor—IL6—metabolic syndrome X	0.000457	0.00071	CbGpPWpGaD
Pimecrolimus—MTOR—ErbB1 downstream signaling—AKT1—metabolic syndrome X	0.000457	0.00071	CbGpPWpGaD
Pimecrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—metabolic syndrome X	0.000457	0.00071	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—AKT1—metabolic syndrome X	0.00045	0.000699	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—VCAM1—metabolic syndrome X	0.000449	0.000699	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GCKR—metabolic syndrome X	0.000449	0.000698	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—APOC3—metabolic syndrome X	0.000441	0.000686	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TRIB3—metabolic syndrome X	0.000433	0.000674	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—AKT1—metabolic syndrome X	0.000425	0.00066	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—APOB—metabolic syndrome X	0.000405	0.00063	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—RBP4—metabolic syndrome X	0.0004	0.000622	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TRIB3—metabolic syndrome X	0.0004	0.000622	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000398	0.000619	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—IL6—metabolic syndrome X	0.000391	0.000608	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—LPL—metabolic syndrome X	0.000387	0.000602	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CYBA—metabolic syndrome X	0.000386	0.0006	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD36—metabolic syndrome X	0.000385	0.000598	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—GHRL—metabolic syndrome X	0.000378	0.000587	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—IL6—metabolic syndrome X	0.000374	0.000582	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD36—metabolic syndrome X	0.000369	0.000574	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—IL6—metabolic syndrome X	0.000368	0.000572	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—AKT1—metabolic syndrome X	0.000361	0.000561	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NAMPT—metabolic syndrome X	0.000359	0.000558	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CNR1—metabolic syndrome X	0.000358	0.000556	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GCK—metabolic syndrome X	0.000357	0.000554	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—AKT1—metabolic syndrome X	0.000355	0.000551	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—APOC3—metabolic syndrome X	0.000354	0.000551	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—IL6—metabolic syndrome X	0.000352	0.000547	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—IL6—metabolic syndrome X	0.00035	0.000544	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	0.000349	0.000542	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—IL6—metabolic syndrome X	0.000348	0.000541	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CRP—metabolic syndrome X	0.000347	0.000539	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—IL6—metabolic syndrome X	0.000346	0.000539	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—AKT1—metabolic syndrome X	0.000345	0.000536	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—AKT1—metabolic syndrome X	0.000341	0.000531	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—AKT1—metabolic syndrome X	0.00034	0.000528	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CYBA—metabolic syndrome X	0.000336	0.000522	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—HMGA1—metabolic syndrome X	0.000326	0.000507	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin Signaling—AKT1—metabolic syndrome X	0.000326	0.000507	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—IL6—metabolic syndrome X	0.000326	0.000507	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—metabolic syndrome X	0.000326	0.000507	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—IL6—metabolic syndrome X	0.000326	0.000507	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—APOE—metabolic syndrome X	0.000324	0.000504	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—AKT1—metabolic syndrome X	0.000324	0.000504	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—IL6—metabolic syndrome X	0.000323	0.000502	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—AKT1—metabolic syndrome X	0.000323	0.000502	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—AKT1—metabolic syndrome X	0.000323	0.000502	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HDAC3—metabolic syndrome X	0.000322	0.0005	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—AKT1—metabolic syndrome X	0.000321	0.000499	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—APOA1—metabolic syndrome X	0.000321	0.000498	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—IL6—metabolic syndrome X	0.00032	0.000498	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—AKT1—metabolic syndrome X	0.00032	0.000497	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—IL6—metabolic syndrome X	0.000319	0.000496	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—metabolic syndrome X	0.000315	0.00049	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GOT2—metabolic syndrome X	0.000311	0.000484	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CYBA—metabolic syndrome X	0.00031	0.000482	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IRS1—metabolic syndrome X	0.000303	0.00047	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—AKT1—metabolic syndrome X	0.000301	0.000467	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—AKT1—metabolic syndrome X	0.000301	0.000467	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—AKT1—metabolic syndrome X	0.000301	0.000467	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—AKT1—metabolic syndrome X	0.000298	0.000463	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—AKT1—metabolic syndrome X	0.000295	0.000459	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—AKT1—metabolic syndrome X	0.000294	0.000457	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IGF2—metabolic syndrome X	0.000292	0.000454	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—IRS1—metabolic syndrome X	0.000291	0.000452	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IRS1—metabolic syndrome X	0.000289	0.00045	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—metabolic syndrome X	0.000289	0.000449	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000288	0.000447	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—APOB—metabolic syndrome X	0.000284	0.000441	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TRIB3—metabolic syndrome X	0.00028	0.000436	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RBP4—metabolic syndrome X	0.00028	0.000436	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—AKT1—metabolic syndrome X	0.000278	0.000433	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SLC2A4—metabolic syndrome X	0.000277	0.000431	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL5—metabolic syndrome X	0.000277	0.000431	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—INS—metabolic syndrome X	0.000277	0.000431	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000276	0.000429	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—VCAM1—metabolic syndrome X	0.000273	0.000424	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—LPL—metabolic syndrome X	0.000271	0.000421	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GOT1—metabolic syndrome X	0.000269	0.000418	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—AKT1—metabolic syndrome X	0.000266	0.000414	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—SERPINE1—metabolic syndrome X	0.000255	0.000396	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APOC3—metabolic syndrome X	0.000248	0.000386	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOS3—metabolic syndrome X	0.000243	0.000378	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL18—metabolic syndrome X	0.000241	0.000375	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—IL6—metabolic syndrome X	0.000237	0.000368	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—AGT—metabolic syndrome X	0.000232	0.00036	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—APOB—metabolic syndrome X	0.000228	0.000354	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—LEP—metabolic syndrome X	0.000227	0.000353	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—APOE—metabolic syndrome X	0.000227	0.000353	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—APOA1—metabolic syndrome X	0.000225	0.000349	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR2C—metabolic syndrome X	0.000224	0.000348	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD36—metabolic syndrome X	0.000224	0.000348	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PTGS2—metabolic syndrome X	0.000222	0.000346	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—IL6—metabolic syndrome X	0.000222	0.000345	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—LPL—metabolic syndrome X	0.000218	0.000338	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CYBA—metabolic syndrome X	0.000217	0.000337	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GHRL—metabolic syndrome X	0.000212	0.00033	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—AKT1—metabolic syndrome X	0.000205	0.000318	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IRS1—metabolic syndrome X	0.000203	0.000315	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CRP—metabolic syndrome X	0.000202	0.000314	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CNR1—metabolic syndrome X	0.000201	0.000313	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—INS—metabolic syndrome X	0.000194	0.000302	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL2—metabolic syndrome X	0.000191	0.000297	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IGF1—metabolic syndrome X	0.000188	0.000292	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—APOE—metabolic syndrome X	0.000182	0.000284	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—APOA1—metabolic syndrome X	0.00018	0.00028	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000178	0.000277	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IRS1—metabolic syndrome X	0.000176	0.000274	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000174	0.00027	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NOS3—metabolic syndrome X	0.00017	0.000265	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IGF2—metabolic syndrome X	0.000164	0.000256	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IRS1—metabolic syndrome X	0.000163	0.000253	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TGFB1—metabolic syndrome X	0.000161	0.00025	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APOB—metabolic syndrome X	0.00016	0.000248	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL5—metabolic syndrome X	0.000156	0.000242	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—INS—metabolic syndrome X	0.000156	0.000242	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000155	0.000241	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000155	0.000241	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000155	0.000241	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—LPL—metabolic syndrome X	0.000152	0.000237	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000146	0.000226	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SERPINE1—metabolic syndrome X	0.000143	0.000223	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS3—metabolic syndrome X	0.000137	0.000212	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—AGT—metabolic syndrome X	0.00013	0.000203	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—LEP—metabolic syndrome X	0.000128	0.000199	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APOE—metabolic syndrome X	0.000128	0.000199	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IL6—metabolic syndrome X	0.000127	0.000197	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APOA1—metabolic syndrome X	0.000126	0.000196	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PTGS2—metabolic syndrome X	0.000125	0.000194	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—FABP4—metabolic syndrome X	0.000124	0.000192	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IL6—metabolic syndrome X	0.000121	0.000188	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	0.000117	0.000182	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—AKT1—metabolic syndrome X	0.000117	0.000182	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IRS1—metabolic syndrome X	0.000114	0.000177	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000113	0.000175	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—AKT1—metabolic syndrome X	0.000112	0.000174	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—AKT1—metabolic syndrome X	0.000112	0.000174	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—INS—metabolic syndrome X	0.000109	0.00017	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL2—metabolic syndrome X	0.000107	0.000167	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IGF1—metabolic syndrome X	0.000106	0.000164	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—G6PD—metabolic syndrome X	0.000105	0.000163	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	0.000102	0.000159	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SERPINE1—metabolic syndrome X	0.0001	0.000156	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GCKR—metabolic syndrome X	9.97e-05	0.000155	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LPA—metabolic syndrome X	9.97e-05	0.000155	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	9.66e-05	0.00015	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NOS3—metabolic syndrome X	9.57e-05	0.000149	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—APOA5—metabolic syndrome X	9.56e-05	0.000149	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TGFB1—metabolic syndrome X	9.04e-05	0.00014	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	8.89e-05	0.000138	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL6—metabolic syndrome X	8.48e-05	0.000132	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	7.97e-05	0.000124	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LIPC—metabolic syndrome X	7.92e-05	0.000123	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GCK—metabolic syndrome X	7.92e-05	0.000123	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—APOC3—metabolic syndrome X	7.87e-05	0.000122	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—AKT1—metabolic syndrome X	7.82e-05	0.000122	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CETP—metabolic syndrome X	7.64e-05	0.000119	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL6—metabolic syndrome X	7.38e-05	0.000115	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	7.32e-05	0.000114	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	7.11e-05	0.00011	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GOT2—metabolic syndrome X	6.91e-05	0.000107	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	6.91e-05	0.000107	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IL6—metabolic syndrome X	6.81e-05	0.000106	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—AKT1—metabolic syndrome X	6.81e-05	0.000106	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TGFB1—metabolic syndrome X	6.33e-05	9.84e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—AKT1—metabolic syndrome X	6.28e-05	9.77e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	6.16e-05	9.58e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	6.16e-05	9.58e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GOT1—metabolic syndrome X	5.97e-05	9.28e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GGT1—metabolic syndrome X	5.97e-05	9.28e-05	CbGpPWpGaD
Pimecrolimus—Tacrolimus—ALB—metabolic syndrome X	5.07e-05	1	CrCbGaD
Pimecrolimus—CYP3A4—Metabolism—APOB—metabolic syndrome X	5.06e-05	7.87e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	4.93e-05	7.66e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LPL—metabolic syndrome X	4.83e-05	7.52e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL6—metabolic syndrome X	4.77e-05	7.41e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CD36—metabolic syndrome X	4.59e-05	7.14e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—AKT1—metabolic syndrome X	4.4e-05	6.84e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PPARA—metabolic syndrome X	4.27e-05	6.64e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—AGT—metabolic syndrome X	4.14e-05	6.43e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—APOE—metabolic syndrome X	4.05e-05	6.3e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—APOA1—metabolic syndrome X	4.01e-05	6.23e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PPARG—metabolic syndrome X	3.53e-05	5.49e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—INS—metabolic syndrome X	3.46e-05	5.38e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALB—metabolic syndrome X	3.17e-05	4.93e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—NOS3—metabolic syndrome X	3.04e-05	4.72e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	2.78e-05	4.32e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.4e-05	2.17e-05	CbGpPWpGaD
